Pharmaceuticals, Biotechnology and Life Sciences
SHERMAN OAKS, Calif.–(BUSINESS WIRE)–T-Cure Bioscience, Inc., a privately held company focused on developing T cell receptor (TCR) therapy products for the treatment of solid tumors, today announced that the Company has entered into a clinical resear…
SAN ANTONIO–(BUSINESS WIRE)–An article published last week in the Journal of Biomedicine & Pharmacotherapy (www.elsevier.com/locate/biopha; Vol 138 (2021) 111457) presents in vitro evidence for significant inhibition of SARS-CoV-2 by oleandrin an…
SAN ANTONIO–(BUSINESS WIRE)–An article published last week in the Journal of Biomedicine & Pharmacotherapy (www.elsevier.com/locate/biopha; Vol 138 (2021) 111457) presents in vitro evidence for significant inhibition of SARS-CoV-2 by oleandrin an…
Study meets primary and key secondary objectives with positive impact and favorable overall safety profile in 21 heavily pre-treated and immunocompromised patients with steroid-resistant, gastrointestinal-predominant aGvHD following stem cell transpl…
DUBLIN–(BUSINESS WIRE)–The “Growth Hormone Deficiency – Global Clinical Trials Review, H1, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering.
“Growth Hormone Deficiency – Global Clinical Trials Review, H1, 2021” provides an o…
DUBLIN–(BUSINESS WIRE)–The “Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Indication; By Distribution Channel; By Regions Segment Forecast, 2020-2027” report has been added to ResearchAndMarkets.c…
DUBLIN–(BUSINESS WIRE)–The “Scientific Research and Development Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030” report has been added to ResearchAndMarkets.com’s offering.
Scientific Research and Development Services Global…
DUBLIN–(BUSINESS WIRE)–The “Scientific Research and Development Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030” report has been added to ResearchAndMarkets.com’s offering.
Scientific Research and Development Services Global…
Promising data supports advancing VS-01 into Phase 2a POC study in Acute on Chronic Liver Failure
ZURICH–(BUSINESS WIRE)–Versantis, a clinical-stage company developing novel therapies for orphan liver and pediatric diseases, today announced positive…
Promising data supports advancing VS-01 into Phase 2a POC study in Acute on Chronic Liver Failure
ZURICH–(BUSINESS WIRE)–Versantis, a clinical-stage company developing novel therapies for orphan liver and pediatric diseases, today announced positive…